Clinical evidence for high-risk CE-marked medical devices for glucose management: A systematic review and meta-analysis
EndocrinologiaSobre o estudo
- Desenho
- Metanálise
- Nível de evidência
- 1 · Evidência consolidada
- Revista
- Diabetes, obesity & metabolism
- Publicado em
- 14 ago 2024
- Citações
- 8
O resumo deste estudo é do publisher e não tem licença aberta: por isso mostramos aqui só os dados do estudo, e o texto fica na fonte original, nos links abaixo.
O estudo original
Clinical evidence for high-risk CE-marked medical devices for glucose management: A systematic review and meta-analysis
Arjola Bano, Juri Künzler, Faina Wehrli, Lum Kastrati, Tania Rivero, Adea Llane, Angelica Valz Gris, Alan G Fraser, Christoph Stettler, Roman Hovorka et al.
Descritores MeSH
- Blood Glucose Self-Monitoring
- Blood Glucose
- Diabetes Mellitus, Type 1
- Insulin
- Insulin Infusion Systems
- Hypoglycemia
- Hypoglycemic Agents
- Infusion Pumps, Implantable
- Randomized Controlled Trials as Topic
- Young Adult
Veja também
Estudos relacionados
- Efficacy and Safety of Tubeless Hybrid Closed-Loop Systems in Type 1 Diabetes: A Meta-Analysis of Randomized Controlled Trials
- Closed-Loop Insulin Delivery in Type 1 Diabetes in Pregnancy: The CIRCUIT Randomized Clinical Trial
- Glycemic control during Ramadan fasting in adolescents and young adults with type 1 diabetes on MiniMed™ 780G advanced hybrid closed‑loop system: A randomized controlled trial
- The use of diabetes technology under aviation conditions: A systematic review of human and in-vitro studies and future considerations